BREAKING
Yuanbao Inc. Fiscal Year 2025 Financial Review 15 minutes ago General Mills, Inc. (GIS) Misses Q3 EPS Estimates by 12.1% 51 minutes ago Red Cat (RCAT) Q4 Revenue Surges 315.8% to $26.2M, Tops Estimates Despite $0.17 Loss 1 hour ago Envela (ELA) Q4 EPS of $0.23 Crushes Estimate by 156%, Revenue Surges 66.6% YoY to $80.5M 2 hours ago Heartflow (HTFL) Stock Surges 13% as Q4 Revenue of $49.1M Beats Estimates Despite $0.12 Loss 2 hours ago DLocal’s Strong 2025 Finish 2 hours ago Micron Technology’s Fiscal Q2 2026 Financial Review 2 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 18 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 18 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 18 hours ago Yuanbao Inc. Fiscal Year 2025 Financial Review 15 minutes ago General Mills, Inc. (GIS) Misses Q3 EPS Estimates by 12.1% 51 minutes ago Red Cat (RCAT) Q4 Revenue Surges 315.8% to $26.2M, Tops Estimates Despite $0.17 Loss 1 hour ago Envela (ELA) Q4 EPS of $0.23 Crushes Estimate by 156%, Revenue Surges 66.6% YoY to $80.5M 2 hours ago Heartflow (HTFL) Stock Surges 13% as Q4 Revenue of $49.1M Beats Estimates Despite $0.12 Loss 2 hours ago DLocal’s Strong 2025 Finish 2 hours ago Micron Technology’s Fiscal Q2 2026 Financial Review 2 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 18 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 18 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 18 hours ago
ADVERTISEMENT
BMY

Bristol-Myers Squibb Company

$BMY NYSE Apr 30, 2026 All Day Q1 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

BMY Coverage

Event Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call Mar 19, 2026 News BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit Mar 11, 2026 Event Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma Mar 9, 2026 Event Bristol-Myers Squibb Company (BMY) U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Mar 7, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers Oct 30, 2025 News Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers Jul 31, 2025